← Back to headlines
AbbVie Seeks EMA Approval for Skyrizi in Crohn’s Disease Treatment
Pharmaceutical company AbbVie has formally submitted an application to the European Medicines Agency for regulatory approval of its biologic drug Skyrizi to treat Crohn’s disease.
27 Aug, 06:33 — 27 Aug, 06:33
Sources
Showing 1 of 1 sources
